2014-005134-64
Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents
Bristol-Myers Squibb Company·EU Clinical Trials Register
Study focus
- Disease/Condition
- HIV Infections
Sponsor & location
- Primary sponsor
- Bristol-Myers Squibb Company
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
For Step 1:
ICD-10 classifications
HIV disease resulting in other viral infectionsHuman immunodeficiency virus [HIV] diseaseHIV disease resulting in other bacterial infectionsAcute HIV infection syndromeUnspecified human immunodeficiency virus [HIV] disease
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2014-005134-64
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2014-005134-64 through Pure Global AI's free database. This phase not specified trial is sponsored by Bristol-Myers Squibb Company and is currently status unknown. The study focuses on HIV Infections.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.